Cocrystal Pharma, Inc. News, Cocrystal Pharma, Inc. Quote, COCP Quote

Cocrystal Pharma, Inc. (NQ:COCP) Delayed: 1.00 +0.03 (3.09%)

Prev. Close

$0.97

Today 6M 1Y 5Y

Open

$0.95

52 Wk High

$0.92

52 Wk Low

$0.32

Day High

$1.00

Day Low

$0.95

P/E

N/A

EPS

$-0.18

Volume

74,320

Friends, Peers and Foes (?): CGTX, FBLG, PDSB, TNXP, 6XB2 (more...)

ALERTS | RSS

Jun 9, 2026 07:00 AM Form 8-K Cocrystal Pharma, Inc. For: Jun 03
Jun 3, 2026 04:11 PM Form 4 Cocrystal Pharma, Inc. For: Jun 03 Filed by: SAPIRSTEIN JAMES
Jun 3, 2026 04:10 PM Form 3 Cocrystal Pharma, Inc. For: Jun 03 Filed by: SAPIRSTEIN JAMES
Jun 3, 2026 07:03 AM Cocrystal Pharma names James Sapirstein as chief executive officer
Jun 3, 2026 07:00 AM Form 8-K Cocrystal Pharma, Inc. For: Jun 03
Jun 3, 2026 07:00 AM Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
May 27, 2026 04:32 PM Form DEFA14A Cocrystal Pharma, Inc.
May 27, 2026 04:31 PM Form DEF 14A Cocrystal Pharma, Inc. For: May 27
May 26, 2026 08:30 AM Form 8-K Cocrystal Pharma, Inc. For: May 26
May 26, 2026 08:05 AM Cocrystal Pharma develops pan-viral inhibitors for hantavirus and influenza

Entities mentioned with COCP

View All Entities